PROTERIXBIO
Developer of proprietary blood-based biomarker tests to transform the management of chronic respiratory diseases. The company is focused on addressing the unmet need for tools to provide a real-time, biological assessment of a patient’s disease state. ProterixBio's products will enable health care providers to better manage their patients and avoid unnecessary hospitalizations, leading to improved outcomes and reduced health care costs. It was founded in 2002 and headquartered in Billerica, Massachusetts.
PROTERIXBIO
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
2002-01-01
Address:
Billerica, Massachusetts, United States
Country:
United States
Website Url:
http://www.proterixbio.com
Total Employee:
11+
Status:
Active
Contact:
+119789016700
Total Funding:
100.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Advisors List
Board_member
Board_member
Advisor
Advisor
Board_member
Advisor
Advisor
Advisor
Current Employees Featured
Michael Miller Chief Executive Officer @ ProterixBio
Chief Executive Officer
2016-11-01
Edward Crawley Co-Founder @ ProterixBio
Co-Founder
Grace Colon Executive Chairman, Board of Directors @ ProterixBio
Executive Chairman, Board of Directors
2016-11-01
Brett Masters Chief Technology Officer @ ProterixBio
Chief Technology Officer
2002-07-01
Founder
Investors List
WFD Ventures
WFD Ventures investment in Series D - ProterixBio
F2 Ventures
F2 Ventures investment in Series D - ProterixBio
New Science Ventures
New Science Ventures investment in Series D - ProterixBio
MF Capital
MF Capital investment in Series D - ProterixBio
Morningside Group
Morningside Group investment in Series D - ProterixBio
New York Angels
New York Angels investment in Venture Round - ProterixBio
Blackfin Technology
Blackfin Technology investment in Venture Round - ProterixBio
Blackfin Technology
Blackfin Technology investment in Series C - ProterixBio
F2 Ventures
F2 Ventures investment in Series C - ProterixBio
New York Angels
New York Angels investment in Series B - ProterixBio
More informations about "ProterixBio"
ProterixBio - Crunchbase Company Profile & Funding
Developer of proprietary blood-based biomarker tests to transform the management of chronic respiratory diseases. The company is focused on addressing the unmet need for tools to …See details»
ProterixBio, Inc - LinkedIn
ProterixBio is developing innovative products to transform the management of chronic diseases. The company is dedicated to providing solutions that benefit patients and reduce health care …See details»
ProterixBio Company Profile 2024: Valuation, Funding ... - PitchBook
What industry is ProterixBio in? ProterixBio’s primary industry is Diagnostic Equipment. Is ProterixBio a private or public company? ProterixBio is a Private company. What is …See details»
ProterixBio, Inc Information - RocketReach
ProterixBio operates a high-complexity, CLIA-certified clinical testing laboratory. We have expertise in the development and validation of quantitative clinical assays for inflammation, …See details»
ProterixBio - Overview, News & Similar companies - ZoomInfo
Jul 1, 2020 ProterixBio is a licensed high-complexity clinical testing laboratory that develops and commercializes diagnostic solutions that address critical u nmet needs in population health …See details»
ProterixBio Inc - Company Profile and News - Bloomberg Markets
Company profile page for ProterixBio Inc including stock price, company news, executives, board members, and contact informationSee details»
PROTERIXBIO, INC. Company Profile | Cumberland, RI
Proterixbio, inc. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united states / rhode island …See details»
Proterixbio - Products, Competitors, Financials, Employees ...
Proterixbio is a company focused on clinical testing and assay development in the healthcare industry. The company offers services such as the development, validation, and …See details»
BioScale Announces Company Name Change to ProterixBio and …
BILLERICA, Mass., May 3, 2016 /PRNewswire/ -- BioScale, Inc. today announced that the company is changing its name to ProterixBio, Inc. The name change reflects a new strategic …See details»
ProterixBio Company Profile - Office Locations, Competitors ... - Craft
ProterixBio has 5 employees at their 1 location and $90.2 m in total funding,. See insights on ProterixBio including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
ProterixBio, Inc. - Scientist.com
ProterixBio is initially focused on chronic pulmonary diseases and has assembled a strong team of experts and key opinion leaders in this field. We are collaborating with leading institutions to …See details»
BioScale Changes Name to ProterixBio, Focus on Pulmonary...
May 10, 2016 ProterixBio will also focus on leveraging its ViBE platform to further its bioassay pipeline. ViBE is a new protein measurement technology to enable clinically sensitive and …See details»
ProterixBio - Contacts, Employees, Board Members, Advisors
Organization. ProterixBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. ProterixBio has 3 current employee profiles, …See details»
ProterixBio, New Name for BioScale, to Focus on Diagnostics for...
May 9, 2016 ProterixBio, Inc., is the new name for the company previously known as BioScale, Inc., reflecting a change in strategy.Whereas BioScale had focused on care management …See details»
BioScale Changes Name to ProterixBio, Shifts Focus From …
May 6, 2016 NEW YORK (GenomeWeb) – Protein assay firm BioScale said this week that it is changing its name to ProterixBio and shifting its focus from instrument development to …See details»
ProterixBio Presents Results from Multiple COPD ... - COPD …
BILLERICA, MA – May 22, 2018 – ProterixBio, Inc. today announced that results from three clinical studies of subjects with chronic obstructive pulmonary disease (COPD) were presented …See details»
ProterixBio Presents Results from Multiple COPD Clinical Studies at …
May 22, 2018 According to World Health Organization estimates, 65 million people worldwide have moderate or severe COPD, and COPD will become the third leading cause of death by …See details»
ProterixBio announces commercial availability of a quantitative …
Feb 11, 2021 ProterixBio is a licensed high-complexity clinical testing laboratory that develops and commercializes diagnostic solutions that address critical unmet needs in population health …See details»
ProterixBio Announces Commercial Offering of Quantitative …
BILLERICA, Mass., Feb. 10, 2023 /PRNewswire/ -- ProterixBio, Inc. today announced the offering of the Presage® ST2 Assay as a testing service through ProterixBio's high-complexity CLIA …See details»
ProterixBio announces commercial availability of a semi …
Sep 29, 2020 ProterixBio is a licensed high-complexity clinical testing laboratory that develops and commercializes diagnostic solutions that address critical unmet needs in population health …See details»